Sublicensing Royalty. In consideration of the license granted hereunder, MBI shall pay to Licensor, without duplication, in respect of any Licensed Products a royalty of [*]% of Sublicensing Revenue collected or received by MBI until the later of either:
Appears in 4 contracts
Samples: Additional Exclusive License Agreement (Med BioGene Inc.), Exclusive License Agreement (Med BioGene Inc.), Exclusive License Agreement (Med BioGene Inc.)
